# OnCo record cancerdetect-imbdx (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/cancerdetect-imbdx/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "cancerdetect-imbdx" ;
  schema:name "CancerDetect"@en ;
  schema:alternateName "IMBdx CancerDetect"@en, "AlphaLiquid Detect"@en, "CancerDetect" ;
  schema:description "IMBdx's personalised blood test for leftover cancer, from Seoul, which adds a set of common treatable mutations to the patient's own."@en ;
  schema:url <https://onco.cc/drugs/cancerdetect-imbdx/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://doi.org/10.1371/journal.pone.0334282> ;
  onco:status "emerging" ;
  onco:tag "test", "mrd" ;
  onco:modality "Tumour-informed ctDNA minimal residual disease test (bespoke variants plus hotspot panel, hybrid capture)" ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/>, <https://onco.cc/technologies/liquid-biopsy/> ;
  onco:companies <https://onco.cc/companies/imbdx/> ;
  onco:terms <https://onco.cc/terms/mrd/>, <https://onco.cc/terms/ctdna/>, <https://onco.cc/terms/tumour-informed-assay/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-heo-cancerdetect-validation-plos-one-2025/> .